Conservative group with pharma ties backs limited drug pricing reform

Conservative group with pharma ties backs limited drug pricing reform

More reads

• Conservative group with pharma ties makes clear there are drug pricing reforms they can support. (STAT)
• Fred Hutch names Thomas Lynch new president. (GeekWire)
• Pear Therapeutics licenses voice biomarkers for dementia and psychiatric disorders. (STAT Plus)
• A Q&A with FDA’s Amy Abernethy on how the agency is grappling with digital health regulation. (STAT Plus)